Search
for
Sort by
Research 481–510 of 1000+
- The Diverse Experiences and Challenges of Individuals With Alopecia Areata: Survey Results From Finland
- The first 20 years of skin of color dermatology: An era of advancements in skin, hair, and nail disorders
- A case of refractory alopecia areata successfully treated by combining delgocitinib ointment with excimer laser
- Pathogenesis of paradoxical alopecia areata during dupilumab therapy: What is known and unknown
- Biologics and Small Molecules for Inflammatory Nail Disorders: A Narrative Review
- Uses of Dupilumab in Dermatology: A Systematic Review of the Randomized Controlled Trials
- Role of topical tofacitinib in autoimmune skin disorders: An expert opinion
- Depressive Disorder and Dermatological Autoimmune Diseases
- Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions
- Cannabinoids and Their Receptors in Skin Diseases
- Epidemiology of alopecia areata and population-wide comorbidities in Germany: analysis of longitudinal claims data
- Exosomes: A Promising Strategy for Repair, Regeneration and Treatment of Skin Disorders
- Prevalence of autoimmune and inflammatory diseases and mental health conditions among an alopecia areata cohort from a US administrative claims database
- Dupilumab Induced Hair Regrowth in Alopecia Totalis
- Melatonin in Dermatologic Allergic Diseases and Other Skin Conditions: Current Trends and Reports
- Bibliometric Study of Adaptogens in Dermatology: Pharmacophylogeny, Phytochemistry, and Pharmacological Mechanisms
- Non-FDA-Approved Uses of Apremilast in Dermatology: A Review of Current Available literature
- No increased risk of alopecia in ankylosing spondylitis patients: A population‐based cohort study in Taiwan
- Seasonal Patterns and Trends in Dermatoses in Poland
- LB943 Tofacitinib treatment of inflammatory skin conditions in patients with Down Syndrome
- Dissecting the Roles of Innate Cells in the Skin and Intractable Skin Diseases
- Prevalence and Risk Factors Associated with the Occurrence of Autoimmune Diseases in Patients with Alopecia Areata
- LB793 A phase 1, open-Label, single ascending dose study in healthy subjects of the safety, tolerability and pharmacokinetics of ASLAN004, a novel IgG anti-IL-13 receptor alpha 1 Inhibitor
- Tyrosine kinase Inhibitors in Dermatology: A Systemic Review
- Bee venom: a case of effectiveness on skin varicosities veins with review of its dermatological benefits
- Influences of skin barrier, a nanoparticle-based vehicle and solvents on cutaneous drug delivery
- Learning and Friendship
- Montagna Symposium 2017—Precision Dermatology: Next Generation Prevention, Diagnosis, and Treatment
- Successful Treatment of Multiple Alopecia Areata With Contact Immunotherapy: Supportive Usage of Oral Antihistamine and Topical Corticosteroid
- Epidermis-specific ablation of claudin-1 in adult mice demonstrates the essential role of a tight junction barrier in skin homeostasis